Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | OPRM1 | P35372 | 14/20 | 0.62 |
| ▸ | OPRD1 | P41143 | 14/20 | 0.62 |
| ▸ | CXCR3 | P49682 | 1/20 | 0.34 |
| ▸ | KCNH2 | Q12809 | 2/20 | 0.34 |
| ▸ | OPRK1 | P41145 | 2/20 | 0.33 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.32 |
| ▸ | PDK1 | Q15118 | 1/20 | 0.32 |
| ▸ | JAK1 | P23458 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL474192 | 0.89 | OPRM1 (0.64) | OPRM1OPRD1CXCR3JAK1 | |
| SCHEMBL12432542 | 0.84 | OPRD1 (0.72) | OPRM1OPRD1CXCR3KCNH2OPRK1 | |
| SCHEMBL12432534 | 0.84 | OPRD1 (0.71) | OPRM1OPRD1CXCR3KCNH2OPRK1 | |
| SCHEMBL474620 | 0.83 | OPRD1 (0.70) | OPRM1OPRD1CXCR3KCNH2OPRK1 | |
| SCHEMBL474169 | 0.80 | OPRD1 (0.65) | OPRM1OPRD1KCNH2OPRK1 | |
| SCHEMBL14228324 | 0.77 | OPRD1 (0.67) | OPRM1OPRD1CXCR3KCNH2OPRK1 | |
| SCHEMBL474239 | 0.77 | HDAC4 (0.35) | OPRM1OPRD1HDAC4PDK1 | |
| Azd-7268 SCHEMBL30248100 | 0.77 | OPRD1 (1.00) | OPRM1OPRD1CXCR3KCNH2 | |
| Azd-7268 SCHEMBL474151 | 0.77 | OPRD1 (1.00) | OPRM1OPRD1CXCR3KCNH2 | |
| SCHEMBL5779506 | 0.74 | OPRM1 (0.49) | OPRM1OPRD1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2079735-B1 | N- (2 -HYDROXYETHYL) -N-METHYL- 4- (QUINOLIN- 8-YL (1- (THIAZOL-4- YLMETHYL) PIPERIDIN- 4 -YLIDENE) METHYL) BENZAMIDE, THE PROCESS OF MAKING IT AS WELL AS ITS USE FOR THE TREATMENT OF PAIN, ANXIETY AND DEPRESSION. | ASTRAZENECA AB (SE) | 2012-02-01 | — | — | EP | claimed |